Upcoming Meetings: CLIA quality control meeting
This article was originally published in The Gray Sheet
CLIA quality control meeting: Centers for Disease Control and Prevention schedules meeting for Sept. 25-26 to discuss "Quality Control Issues Relevant to Regulations Under the Clinical Laboratory Improvement Amendments" at CDC headquarters in Atlanta. Items on the agenda include: "the ability of current test systems to assess the potential for error in the total testing process"; "processes to monitor the quality of clinical laboratory results over time"; and "processes to assess appropriate operator performance." The committee will hear input from industry reps on the first day and other health professionals the second day; comments will be considered by CDC in the development of final CLIA regs for quality control. For further information, contact CDC's Julie Wasil at 770/488-4651...
You may also be interested in...
Third round of orders would give the US all the vaccine it needs from the existing mRNA products, taking pressure off AstraZeneca is it experiences manufacturing challenges and the EU considers export restrictions to ensure it gets enough vaccine.
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
Nutritional Brands rolls out NB Pure as brand, including logo, packaging design and website, for all its supplements after 25 years. “When you looked at our label for one brand and looked at the label for another brand, there was no symmetry between the two,” says CEO Danna Pratt.